Functional crosstalk between membrane lipids and TLR biology

Current Opinion in Cell Biology

Volumn 39, Issue , 2016, Pages 28-36

  Köberlin, Marielle S ^a,c   Heinz, Leonhard X ^a   Superti Furga, Giulio ^a,b  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CERAMIDASE; ALPHA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE ALPHA CHAIN; BETA N ACETYLHEXOSAMINIDASE BETA CHAIN; CHOLESTEROL; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GALACTOSYLCERAMIDASE; GLOBOTRIAOSYLCERAMIDE; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; GLYCEROPHOSPHOLIPID; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL; RANTES; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR; CYTOKINE;

ATHEROSCLEROSIS; CELL MEMBRANE; CHEDIAK HIGASHI SYNDROME; CYTOKINE RELEASE; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOCYTOSIS; FABRY DISEASE; GAUCHER DISEASE; GLOBOID CELL LEUKODYSTROPHY; HUMAN; HYDROLYSIS; IMMUNE RESPONSE; LEISHMANIASIS; LIPID METABOLISM; LIPIDOSIS; MYRISTYLATION; NEURONAL CEROID LIPOFUSCINOSIS; NIEMANN PICK DISEASE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW; SANDHOFF DISEASE; TAY SACHS DISEASE; ANIMAL; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; ENDOCYTOSIS; HUMANS; INFLAMMATION; MEMBRANE LIPIDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84958211912     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2016.01.010     Document Type: Review

References (88)

1. Gay N.J., Symmons M.F., Gangloff M., Bryant C.E. Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol 2014, 14:546-558.
2. Kawasaki T., Kawai T. Toll-like receptor signaling pathways. Front Immunol 2014, 5:461.
3. van Meer G., Voelker D.R., Feigenson G.W. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 2008, 9:112-124.
4. Wenk M.R. Lipidomics: new tools and applications. Cell 2010, 143:888-895.
5. Gavin A.C., Bosche M., Krause R., Grandi P., Marzioch M., Bauer A., Schultz J., Rick J.M., Michon A.M., Cruciat C.M., et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 2002, 415:141-147.
6. Shamshiev A.T., Ampenberger F., Ernst B., Rohrer L., Marsland B.J., Kopf M. Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity. J Exp Med 2007, 204:441-452.
7. de Bont N., Netea M.G., Demacker P.N., Verschueren I., Kullberg B.J., van Dijk K.W., van der Meer J.W., Stalenhoef A.F. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 1999, 40:680-685.
8. Ludewig B., Jaggi M., Dumrese T., Brduscha-Riem K., Odermatt B., Hengartner H., Zinkernagel R.M. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses. J Immunol 2001, 166:3369-3376.
9. Khovidhunkit W., Kim M.S., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004, 45:1169-1196.
10. Levine D.M., Parker T.S., Donnelly T.M., Walsh A., Rubin A.L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A 1993, 90:12040-12044.
11. Glass C.K., Olefsky J.M. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 2012, 15:635-645.
12. Jin C., Henao-Mejia J., Flavell R.A. Innate immune receptors: key regulators of metabolic disease progression. Cell Metab 2013, 17:873-882.
13. Köberlin M.S., Snijder B., Heinz L.X., Baumann C.L., Fauster A., Vladimer G.I., Gavin A.C., Superti-Furga G. A conserved circular network of coregulated lipids modulates innate immune responses. Cell 2015, 162:170-183.
14. Ward D.M., Shiflett S.L., Kaplan J. Chediak-Higashi syndrome: a clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med 2002, 2:469-477.
15. Safyan R., Whybra C., Beck M., Elstein D., Altarescu G. An association study of inflammatory cytokine gene polymorphisms in Fabry disease. Eur Cytokine Netw 2006, 17:271-275.
16. Vitner E.B., Farfel-Becker T., Eilam R., Biton I., Futerman A.H. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease. Brain 2012, 135:1724-1735.
17. Allen M.J., Myer B.J., Khokher A.M., Rushton N., Cox T.M. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-and interleukin-10. QJM 1997, 90:19-25.
18. Castaneda J.A., Lim M.J., Cooper J.D., Pearce D.A. Immune system irregularities in lysosomal storage disorders. Acta Neuropathol 2008, 115:159-174.
19. Brinkmann M.M., Spooner E., Hoebe K., Beutler B., Ploegh H.L., Kim Y.M. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007, 177:265-275.
20. Godfroy J.I., Roostan M., Moroz Y.S., Korendovych I.V., Yin H. Isolated Toll-like receptor transmembrane domains are capable of oligomerization. PLoS ONE 2012, 7:e48875.
21. Reuven E.M., Fink A., Shai Y. Regulation of innate immune responses by transmembrane interactions: lessons from the TLR family. Biochim Biophys Acta 2014, 1838:1586-1593.
22. Liaunardy-Jopeace A., Bryant C.E., Gay N.J. The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membrane. Sci Signal 2014, 7:ra70.
23. Wakabayashi Y., Kobayashi M., Akashi-Takamura S., Tanimura N., Konno K., Takahashi K., Ishii T., Mizutani T., Iba H., Kouro T., et al. A protein associated with toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4. J Immunol 2006, 177:1772-1779.
24. Yang Y., Liu B., Dai J., Srivastava P.K., Zammit D.J., Lefrancois L., Li Z. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 2007, 26:215-226.
25. Hedger G., Sansom M.S., Koldso H. The juxtamembrane regions of human receptor tyrosine kinases exhibit conserved interaction sites with anionic lipids. Sci Rep 2015, 5:9198.
26. Chesarino N.M., Hach J.C., Chen J.L., Zaro B.W., Rajaram M.V., Turner J., Schlesinger L.S., Pratt M.R., Hang H.C., Yount J.S. Chemoproteomics reveals Toll-like receptor fatty acylation. BMC Biol 2014, 12:91.
27. Levental I., Grzybek M., Simons K. Greasing their way: lipid modifications determine protein association with membrane rafts. Biochemistry 2010, 49:6305-6316.
28. Levental I., Lingwood D., Grzybek M., Coskun U., Simons K. Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc Natl Acad Sci U S A 2010, 107:22050-22054.
29. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007, 7:353-364.
30. Bonham K.S., Orzalli M.H., Hayashi K., Wolf A.I., Glanemann C., Weninger W., Iwasaki A., Knipe D.M., Kagan J.C. A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction. Cell 2014, 156:705-716.
31. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-signal transduction. Nature 2001, 413:78-83.
32. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002, 420:324-329.
33. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125:943-955.
34. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008, 9:361-368.
35. Tanimura N., Saitoh S., Matsumoto F., Akashi-Takamura S., Miyake K. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys Res Commun 2008, 368:94-99.
36. Rowe D.C., McGettrick A.F., Latz E., Monks B.G., Gay N.J., Yamamoto M., Akira S., O'Neill L.A., Fitzgerald K.A., Golenbock D.T. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc Natl Acad Sci U S A 2006, 103:6299-6304.
37. Chiang C.Y., Veckman V., Limmer K., David M. Phospholipase Cgamma-and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J Biol Chem 2012, 287:3704-3709.
38. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147:868-880.
39. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 2002, 115:2603-2611.
40. Triantafilou M., Morath S., Mackie A., Hartung T., Triantafilou K. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 2004, 117:4007-4014.
41. Zhu X., Owen J.S., Wilson M.D., Li H., Griffiths G.L., Thomas M.J., Hiltbold E.M., Fessler M.B., Parks J.S. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res 2010, 51:3196-3206.
42. Fessler M.B., Parks J.S. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol 2011, 187:1529-1535.
43. Yvan-Charvet L., Welch C., Pagler T.A., Ranalletta M., Lamkanfi M., Han S., Ishibashi M., Li R., Wang N., Tall A.R. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 2008, 118:1837-1847.
44. Koseki M., Hirano K., Masuda D., Ikegami C., Tanaka M., Ota A., Sandoval J.C., Nakagawa-Toyama Y., Sato S.B., Kobayashi T., et al. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages. J Lipid Res 2007, 48:299-306.
45. Zhu X., Lee J.Y., Timmins J.M., Brown J.M., Boudyguina E., Mulya A., Gebre A.K., Willingham M.C., Hiltbold E.M., Mishra N., et al. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem 2008, 283:22930-22941.
46. Ito A., Hong C., Rong X., Zhu X., Tarling E.J., Hedde P.N., Gratton E., Parks J., Tontonoz P. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. Elife 2015, 4:e08009.
47. Chansrichavala P., Chantharaksri U., Sritara P., Ngaosuwankul N., Chaiyaroj S.C. Atorvastatin affects TLR4 clustering via lipid raft modulation. Int Immunopharmacol 2010, 10:892-899.
48. Heinz L.X., Baumann C.L., Köberlin M.S., Snijder B., Gawish R., Shui G., Sharif O., Aspalter I.M., Muller A.C., Kandasamy R.K., et al. The lipid-modifying enzyme SMPDL3B negatively regulates innate immunity. Cell Rep 2015, 11:1919-1928.
49. Hailemariam T.K., Huan C., Liu J., Li Z., Roman C., Kalbfeisch M., Bui H.H., Peake D.A., Kuo M.S., Cao G., et al. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation. Arterioscler Thromb Vasc Biol 2008, 28:1519-1526.
50. Li Z., Fan Y., Liu J., Li Y., Huan C., Bui H.H., Kuo M.S., Park T.S., Cao G., Jiang X.C. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012, 32:1577-1584.
51. Chakraborty M., Lou C., Huan C., Kuo M.S., Park T.S., Cao G., Jiang X.C. Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis. J Clin Invest 2013, 123:1784-1797.
52. Ali M., Fritsch J., Zigdon H., Pewzner-Jung Y., Schutze S., Futerman A.H. Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization. Cell Death Dis 2013, 4:e929.
53. Cai W., Du A., Feng K., Zhao X., Qian L., Ostrom R.S., Xu C. Adenylyl cyclase 6 activation negatively regulates TLR4 signaling through lipid raft-mediated endocytosis. J Immunol 2013, 191:6093-6100.
54. Contreras F.X., Ernst A.M., Wieland F., Brugger B. Specificity of intramembrane protein-lipid interactions. Cold Spring Harb Perspect Biol 2011, 3.
55. Yeagle P.L. Non-covalent binding of membrane lipids to membrane proteins. Biochim Biophys Acta 2014, 1838:1548-1559.
56. Saliba A.E., Vonkova I., Gavin A.C. The systematic analysis of protein-lipid interactions comes of age. Nat Rev Mol Cell Biol 2015, 16:753-761.
57. Gonen T., Sliz P., Kistler J., Cheng Y., Walz T. Aquaporin-membrane junctions reveal the structure of a closed water pore. Nature 2004, 429:193-197.
58. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
59. Hanson M.A., Cherezov V., Griffith M.T., Roth C.B., Jaakola V.P., Chien E.Y., Velasquez J., Kuhn P., Stevens R.C. A specific cholesterol binding site is established by the 2.8. A structure of the human beta2-adrenergic receptor. Structure 2008, 16:897-905.
60. Ruysschaert J.M., Lonez C. Role of lipid microdomains in TLR-mediated signalling. Biochim Biophys Acta 2015, 1848:1860-1867.
61. Hulce J.J., Cognetta A.B., Niphakis M.J., Tully S.E., Cravatt B.F. Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells. Nat Methods 2013, 10:259-264.
62. Contreras F.X., Ernst A.M., Haberkant P., Bjorkholm P., Lindahl E., Gonen B., Tischer C., Elofsson A., von Heijne G., Thiele C., et al. Molecular recognition of a single sphingolipid species by a protein's transmembrane domain. Nature 2012, 481:525-529.
63. Parker L.C., Prestwich E.C., Ward J.R., Smythe E., Berry A., Triantafilou M., Triantafilou K., Sabroe I. A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains. J Immunol 2008, 181:5606-5617.
64. Bechara C., Robinson C.V. Different modes of lipid binding to membrane proteins probed by mass spectrometry. J Am Chem Soc 2015, 137:5240-5247.
65. Tian Y., Pate C., Andreolotti A., Wang L., Tuomanen E., Boyd K., Claro E., Jackowski S. Cytokine secretion requires phosphatidylcholine synthesis. J Cell Biol 2008, 181:945-957.
66. Low P.C., Misaki R., Schroder K., Stanley A.C., Sweet M.J., Teasdale R.D., Vanhaesebroeck B., Meunier F.A., Taguchi T., Stow J.L. Phosphoinositide 3-kinase delta regulates membrane fission of Golgi carriers for selective cytokine secretion. J Cell Biol 2010, 190:1053-1065.
67. Pinot M., Vanni S., Pagnotta S., Lacas-Gervais S., Payet L.A., Ferreira T., Gautier R., Goud B., Antonny B., Barelli H. Lipid cell biology. Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins. Science 2014, 345:693-697.
68. Dennis E.A., Deems R.A., Harkewicz R., Quehenberger O., Brown H.A., Milne S.B., Myers D.S., Glass C.K., Hardiman G., Reichart D., et al. A mouse macrophage lipidome. J Biol Chem 2010, 285:39976-39985.
69. Ejsing C.S., Sampaio J.L., Surendranath V., Duchoslav E., Ekroos K., Klemm R.W., Simons K., Shevchenko A. Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry. Proc Natl Acad Sci U S A 2009, 106:2136-2141.
70. da Silveira Dos Santos A.X., Riezman I., Aguilera-Romero M.A., David F., Piccolis M., Loewith R., Schaad O., Riezman H. Systematic lipidomic analysis of yeast protein kinase and phosphatase mutants reveals novel insights into regulation of lipid, homeostasis. Mol Biol Cell 2014, 25:3234-3246.
71. Niphakis M.J., Lum K.M., Cognetta A.B., Correia B.E., Ichu T.A., Olucha J., Brown S.J., Kundu S., Piscitelli F., Rosen H., et al. A global map of lipid-binding proteins and their ligandability in cells. Cell 2015, 161:1668-1680.
72. Maeda K., Anand K., Chiapparino A., Kumar A., Poletto M., Kaksonen M., Gavin A.C. Interactome map uncovers phosphatidylserine transport by oxysterol-binding proteins. Nature 2013, 501:257-261.
73. Atilla-Gokcumen G.E., Muro E., Relat-Goberna J., Sasse S., Bedigian A., Coughlin M.L., Garcia-Manyes S., Eggert U.S. Dividing cells regulate their lipid composition and localization. Cell 2014, 156:428-439.
74. Pettus B.J., Chalfant C.E., Hannun Y.A. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 2002, 1585:114-125.
75. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A.M., Czaja M.J. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
76. 2+, diacylglycerol and STIM1 signalling system regulates directed cell migration. Nat Cell Biol 2014, 16:133-144.
77. De Francesco P.N., Mucci J.M., Ceci R., Fossati C.A., Rozenfeld P.A. Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide. Mol Genet Metab 2013, 109:93-99.
78. Campeau P.M., Rafei M., Boivin M.N., Sun Y., Grabowski G.A., Galipeau J. Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome. Blood 2009, 114:3181-3190.
79. LeVine S.M., Brown D.C. IL-and TNFalpha expression in brains of twitcher, quaking and normal mice. J Neuroimmunol 1997, 73:47-56.
80. Giri S., Jatana M., Rattan R., Won J.S., Singh I., Singh A.K. Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-and C/EBP: implications for Krabbe disease. FASEB J 2002, 16:661-672.
81. Perry D.M., Newcomb B., Adada M., Wu B.X., Roddy P., Kitatani K., Siskind L., Obeid L.M., Hannun Y.A. Defining a role for acid sphingomyelinase in the p38/interleukin-pathway. J Biol Chem 2014, 289:22401-22412.
82. Cologna S.M., Cluzeau C.V., Yanjanin N.M., Blank P.S., Dail M.K., Siebel S., Toth C.L., Wassif C.A., Lieberman A.P., Porter F.D. Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1. J Inherit Metab Dis 2014, 37:83-92.
83. Wang L., Kantovitz K.R., Cullinane A.R., Nociti F.H., Foster B.L., Roney J.C., Tran A.B., Introne W.J., Somerman M.J. Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response. Orphanet J Rare Dis 2014, 9:212.
84. Gil-Krzewska A., Wood S.M., Murakami Y., Nguyen V., Cher Chiang S.C., Cullinane A.R., Peruzzi G., Gahl W.A., Coligan J.E., Introne W.J., et al. Chediak-Higashi syndrome: Lysosomal trafficking regulator domains regulate exocytosis of lytic granules but not cytokine secretion by natural killer cells. J Allergy Clin Immunol 2015, in press - corrected proof.
85. Xiong J., Kielian T. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype. J Neurochem 2013, 127:245-258.
86. Jeyakumar M., Thomas R., Elliot-Smith E., Smith D.A., van der Spoel A.C., d'Azzo A., Perry V.H., Butters T.D., Dwek R.A., Platt F.M. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 2003, 126:974-987.
87. Tsuji D., Kuroki A., Ishibashi Y., Itakura T., Kuwahara J., Yamanaka S., Itoh K. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates. J Neurochem 2005, 92:1497-1507.
88. Hayase T., Shimizu J., Goto T., Nozaki Y., Mori M., Takahashi N., Namba E., Yamagata T., Momoi M.Y. Unilaterally and rapidly progressing white matter lesion and elevated cytokines in a patient with Tay-Sachs disease. Brain Dev 2010, 32:244-247.